MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
38 hedge funds and large institutions have $29.5M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
82% less call options, than puts
Call options by funds: $180K | Put options by funds: $990K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
38
Holding in Top 10
–
Calls
$180K
Puts
$990K
Top Buyers
| 1 | +$107K | |
| 2 | +$52K | |
| 3 | +$50.1K | |
| 4 |
BlackRock
New York
|
+$6.31K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.01K |
Top Sellers
| 1 | -$380K | |
| 2 | -$168K | |
| 3 | -$152K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$65K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$51K |